CD36 and glioblastoma: Finally, we investigated the relation of the identified CD44+/CD133+/ITGA6+/CD36+ signature to the four glioblastoma molecular subtypes (mesenchymal, neural, proneural, and classical) as well as the isocitrate dehydrogenase 1 (IDH1) status.